Stable and high expression of Galectin-8 tightly controls metastatic progression of prostate cancer

This publication has 39 references indexed in Scilit:

• Metastatic Progression of Prostate Cancer Is Mediated by Autonomous Binding of Galectin-4-O-Glycan to Cancer Cells
  Cancer Research, 2016
• Galectins: Major Signaling Modulators Inside and Outside the Cell
  Current Molecular Medicine, 2014
• Platelet-Derived Nucleotides Promote Tumor-Cell Transendothelial Migration and Metastasis via P2Y2 Receptor
  Cancer Cell, 2013
• Regulatory Circuits Mediated by Lectin-Glycan Interactions in Autoimmunity and Cancer
  Immunity, 2012
• Stemness markers characterize IGR-CaP1, a new cell line derived from primary epithelial prostate cancer
  Experimental Cell Research, 2011
• Galectin-1 sensitizes carcinoma cells to anoikis via the fibronectin receptor α5β1-integrin
  Cell Death & Differentiation, 2010
• Tumor suppressor p16^INK4a: Downregulation of galectin‐3, an endogenous competitor of the pro‐anoikis effector galectin‐1, in a pancreatic carcinoma model
  The FEBS Journal, 2010
• Dissecting the signal transduction pathways triggered by galectin–glycan interactions in physiological and pathological settings
  IUBMB Life, 2009
• Human Disease Glycomics/Proteome Initiative Workshop and the 4 ^th HUPO Annual Congress
  Proteomics, 2006
• Galectin-1 expression in prostate tumor-associated capillary endothelial cells is increased by prostate carcinoma cells and modulates heterotypic cell–cell adhesion
  Angiogenesis, 1999